PedAM
Pediatric Disease Annotations & Medicines
| Disease | cystic fibrosis |
| Symptom | |infection |
| Sentences | 128 |
| PubMedID- 23031195 | Chronic pulmonary infection is the hallmark of cystic fibrosis (cf) lung disease. |
| PubMedID- 26534255 | Adherence to inhaled antibiotics for the treatment of chronic pseudomonas aeruginosa infection in patients with cystic fibrosis: a systematic literature review. |
| PubMedID- 21511763 | P. aeruginosa infections associated with cystic fibrosis are resistant to current therapies, and molecules inhibiting toxin production or signals controlling their production should be able to reduce infection and aid in the clearance of this pathogen. |
| PubMedID- 24851825 | Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. |
| PubMedID- 25417708 | Levofloxacin inhalation solution for the treatment of chronic pseudomonas aeruginosa infection among patients with cystic fibrosis. |
| PubMedID- 22869452 | Mycobacterium tuberculosis infection in patients with cystic fibrosis (cf) is rare. |
| PubMedID- 22785192 | The genus achromobacter currently is comprised of seven species, including achromobacter xylosoxidans, an opportunistic and nosocomial pathogen that displays broad-spectrum antimicrobial resistance and is recognized as causing chronic respiratory tract infection in persons with cystic fibrosis (cf). |
| PubMedID- 25624972 | Lung disease in cystic fibrosis results from chronic airway infection and inflammation leading to progressive bronchiectasis and respiratory failure . |
| PubMedID- 21189901 | Results reveal that they have a potential role as a novel antimicrobial agent for the treatment of infection due to cystic fibrosis (cf)-related opportunistic pathogens. |
| PubMedID- 25657265 | Pandoraea is an emerging respiratory pathogen capable of causing chronic lung infections in people with cystic fibrosis (cf), but the clinical significance of this infection is ambiguous. |
| PubMedID- 22905192 | It is a leading cause of acute pneumonia in hospitalized patients and is responsible for chronic lung infection in patients with cystic fibrosis. |
| PubMedID- 25191584 | (150)hydrogen cyanide is released by the pathogen,pseudomonas aeruginosa, and the detection of highconcentrations of hydrogen cyanide in breath may be used for the early detectionof bacterial infection of children with cystic fibrosisshestivska et al. |
| PubMedID- 21039067 | We present the case of a cystic fibrosis-young man diagnosed with hcv infection during lt assessment who was treated with pegi/r. |
| PubMedID- 20950421 | M. abscessus has been described as a prevalent ntm infection in children with cystic fibrosis 9. |
| PubMedID- 21114855 | For example, in this study, the target proteins were from p. aeruginosa, a gram negative bacterial opportunistic pathogen that causes serious lung infections in people with cystic fibrosis, and several tm proteins involved in infection were found to be expressed at sufficient levels for further study. |
| PubMedID- 22230402 | Aeruginosa causes chronic lung infection in individuals with cystic fibrosis and nosocomial pneumonia resulting in significant morbidity and mortality. |
| PubMedID- 22396480 | This is particularly true for the treatment of pseudomonas infection in patients with cystic fibrosis. |
| PubMedID- 24194436 | Tobramycin inhalation powder: a review of its use in the treatment of chronic pseudomonas aeruginosa infection in patients with cystic fibrosis. |
| PubMedID- 21883670 | Initial pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates. |
| PubMedID- 20927769 | Authors' conclusions: we could not identify an antibiotic adjuvant therapy that could be recommended for the treatment of lung infection in those with cystic fibrosis. |
| PubMedID- 25241695 | Human rhinovirus infection in children with cystic fibrosis. |
| PubMedID- 20942647 | Aeruginosa cell counts in a rat lung infection model and in patients with cystic fibrosis. |
| PubMedID- 21703477 | Inhaled antibiotics have been used for more than 30 years to treat bronchial colonization or infection, especially in patients with cystic fibrosis and chronic bronchial infection with pseudomonas. |
| PubMedID- 24068273 | Pseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatment. |
| PubMedID- 20098291 | The risk of mold infection was higher in patients with cystic fibrosis (11%, 4 of 35) than other underlying lung diseases (4%, 10 of 269). |
| PubMedID- 23550133 | 2011), and chronic pseudomonas aeruginosa infection associated with cystic fibrosis involves selection against virulence factors required for an acute infection (smith et al. |
| PubMedID- 25470304 | Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. |
| PubMedID- 25146522 | Aeruginosa infection in patients with cystic fibrosis. |